Sener G, Omurtag GZ, Sehirli O, et al
GLP-1 receptor agonists (GLP-1 RAs) are a class of medications that mimic glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the gut
(A head-to-head trial of the two medications, funded by Eli Lilly, found that patients on Zepbound lost an average of 20 percent of their weight, versus about 14 percent for those on Wegovy.) Nevertheless, its much harder to get Zepbound than Wegovy
Peripheral arterial disease
Most conventional physicians doubt that too much of a particular yeast can cause the digestive and cognitive issues Delaney experienced, even as conditions such as thrush, diaper rash, and vaginal yeast infections are commonly attributed to yeast overgrowth